Zimmer Biomet beat Q3 topline estimates, updates guidance

Zimmer Biomet press release ( NYSE: ZBH ): Q3 Non-GAAP EPS of $1.74 in-line. Revenue of $1.

82B (+4.0% Y/Y) beats by $30M . Financial Guidance The Company is updating its full-year 2024 financial guidance to reduce and narrow its previous projected ranges for revenue.